Hospital execs express concern over ‘clinical meaningfulness’ of quality reporting

 

While quality reporting helps stimulate improvement initiatives, hospital executives see little correlation with clinical outcomes, according to a study published in JAMA Internal Medicine.

Researchers surveyed leaders at 380 hospitals. While 70 percent of hospitals agreed that public reporting spurs quality improvement activity, they expressed concerns about the clinical meaningfulness, unintended consequence and methods of public reporting.

Read more below: 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.